Skip to main content
. Author manuscript; available in PMC: 2020 May 19.
Published in final edited form as: Genet Med. 2019 Jun 4;21(11):2442–2452. doi: 10.1038/s41436-019-0535-9

Table 2.

Summary statistics for p.Met34Thr

All1 Cases2 Population3 Counsyl OR 95% CI Z P value
Total number of individuals tested for GJB2 17635 802339 654426
Total number of alleles tested for GJB2 35270 1604678 1308852
Total number of individuals with p.Met34Thr 391 10835 8336
Total number of p.Met34Thr heterozygotes 362 10754 8282
Total number of p.Met34Thr homozygotes 29 81 54 16 11–25 13 <0.0001
Total number of p.Met34Thr compound heterozygotes4 147 NA5 135
Total number of p.Met34Thr alleles 420 10916 8390
Overall p.Met34Thr allele frequency 0.0119 0.0068 0.0064
Number of European individuals tested for GJB2 7962 382842 304433
Number of European alleles tested for GJB2 15924 765684 608866
Number of European individuals with p.Met34Thr 207 7915 5769
Number of European p.Met34Thr heterozygotes 193 7846 5725
Number of European p.Met34Thr homozygotes 14 69 44 9.8 5.5–17 7.8 <0.0001
Number of European p.Met34Thr compound heterozygotes4 with another GJB2 pathogenic allele 84 N/A5 886 296 22–376 256 <0.00016
Number of European p.Met34Thr alleles 221 7984 5813 1.3 1.2–1.5 4.2 <0.0001
p.Met34Thr allele frequency in Europeans 0.0139 0.0104 0.0095
1.

Only probands (unrelated individuals) were counted. However, we could not rule out the possibility of related cases from different sites because cases were de-identified before being shared. Nevertheless, the likelihood of such occurrence would be low and would not significantly impact the conclusion.

2.

The total number of cases included in statistical analyses did not include BCH, DY, and GDWC where the total number of individuals tested at these sites were not available.

3.

The total population data were from Counsyl, CUHK, TAU, UNC, and gnomAD.

4.

Compound heterozygosity was presumed in individuals with a second pathogenic or likely pathogenic variant in GJB2 that had never been reported to have occurred in cis.

5.

NA: Not available, because individual allele state information is not available from gnomAD.

6.

Analyses involving compound heterozygotes were performed using Counsyl data as the population control (see Methods).